Onderneming Pieris Pharmaceuticals, Inc.
Aandelen
PIRS
US7207952026
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
11,72 USD | +1,03% | +1,03% | -19,51% |
Vakgebied
Aantal werknemers: 48
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Biotechnological Applications
100,0
%
| 26 | 100,0 % | 43 | 100,0 % | +65,28% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States, Germany and Australia
100,0
%
| 26 | 100,0 % | 43 | 100,0 % | +65,28% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Yoder
CEO | Chief Executive Officer | 48 | 01-01-10 |
Thomas Bures
DFI | Director of Finance/CFO | 49 | 01-12-17 |
Kayti Aviano
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-17 |
Hitto Kaufmann
CTO | Chief Tech/Sci/R&D Officer | 53 | 30-08-19 |
Shane Olwill
PRN | Corporate Officer/Principal | 48 | 01-06-11 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 59 | 20-09-16 | |
James Geraghty
CHM | Chairman | 70 | 22-05-17 |
Michael Richman
BRD | Director/Board Member | 63 | 17-12-14 |
Matthew Sherman
BRD | Director/Board Member | 68 | 25-10-18 |
Peter Kiener
BRD | Director/Board Member | 72 | 10-09-18 |
Stephen Yoder
CEO | Chief Executive Officer | 48 | 01-01-10 |
Maya Said
BRD | Director/Board Member | 47 | 31-07-19 |
Ann Barbier
BRD | Director/Board Member | 59 | 25-04-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 3 506 | 0 | 0 | 92,57 % |
Aandeel B | 0 | 4 026 | 0 | 0 | |
Aandeel C | 1 | 1 236 688 | 1 144 742 ( 92,57 %) | 0 | |
Aandeel D | 0 | 85 | 0 | 0 |
Bedrijfsgegevens
Pieris Pharmaceuticals, Inc.
225 Franklin Street 9th floor
02109, Boston
+857 246 8998
http://www.pieris.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-19,51% | 14,49 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |
- Beurs
- Aandelen
- Koers PIRS
- Onderneming Pieris Pharmaceuticals, Inc.